The ET Edge Diabetes India Summit 2025 presented by Mankind Pharma in association with Association of Healthcare Providers and Private Hospitals & Nursing Homes Association (PHANA) themed The Future of Diabetes: Digital Solutions & Clinical Excellence, brought together leading experts, medical professionals, and healthcare innovators to address one of India’s most pressing health challenges—diabetes. With India among the countries with the highest diabetes prevalence globally, the summit served as a critical platform for knowledge exchange, innovation, and collaborative action.

Keynote Highlights

‘Made in Bharat’ to Global Leadership: India’s Path to Becoming the Diabetes Care Capital of the World Dr. Sandip Mitra, Sr. Vice President of Global Medical Affairs at Mankind Pharma Ltd., delivered a compelling keynote on India’s role in diabetes care on a global scale. He highlighted how India is not only home to world-class research and pharmaceutical advancements but is also paving the way for accessible and affordable diabetes treatments. His session underscored India’s potential to emerge as the global hub for diabetes management and innovation.

Obesity and Type 2 Diabetes in 40s: A Different Panorama in India Dr. Shailaja Kale, MD FRCP (London) FACE, Director of SKDC Diabetes & Specialty Clinics, took the stage to discuss the intricate relationship between obesity and Type 2 diabetes in the Indian population. She emphasized the unique genetic, lifestyle, and dietary factors that make diabetes prevention and management in India distinct from Western models, urging for tailored approaches to tackle the epidemic effectively.

Transformative Panel Discussion

A key session of the summit, Bridging the Gap: Empowering Diabetes Care through Enhanced Doctor-Patient Interactions and Psychosocial Support in India, featured leading experts:

Dr. Pratap P. Jethwani (Jethwani Hospital, Rajkot)

Dr. Arvind Gupta (Rajasthan Hospital, Jaipur)

Dr. Rajiv Singla (Kalpavriksh Superspeciality Centre, Delhi)

Dr. Kalyan Kumar Gangopadhyay (CMRI & Peerless Hospitals, Kolkata)

Dr. Prasanth Shankar (MGM Muthoot Hospitals, Pathanamthitta)

Moderated by Dr. Sunil S Gupta, the discussion delved into the importance of holistic diabetes management, emphasizing how enhanced doctor-patient communication and psychosocial support play a pivotal role in treatment adherence and improved outcomes. Panelists explored innovative patient engagement strategies, digital health interventions, and community-driven care models.

Engaging On-Ground Activity: A Test of Precision

Beyond insightful discussions, the summit featured an engaging activity designed to emphasize the precision required in diabetes care. Attendees participated in a unique challenge where they had to insert a syringe into a balloon without popping it, mirroring the meticulous skill and care that diabetologists and endocrinologists apply in their daily practice. This lighthearted yet meaningful activity added an interactive and memorable dimension to the event.

A Future-Forward Approach

The ET Edge Diabetes India Summit 2025 presented by Mankind Pharma in association with Association of Healthcare Providers and Private Hospitals & Nursing Homes Association (PHANA) successfully provided a comprehensive roadmap for the future of diabetes care, merging cutting-edge research with practical solutions. By spotlighting digital interventions, fostering interdisciplinary collaborations, and celebrating the contributions of India’s leading diabetologists and endocrinologists, the summit reaffirmed its role as a cornerstone event in India’s fight against diabetes.

As the nation continues to innovate and evolve in healthcare, this summit stands as a testament to the collective efforts driving a healthier and diabetes-free future for India.

(DISCLAIMER: The information in this article does not necessarily reflect the views of The Global Hues. We make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information in this article.)